United Imaging Healthcare Announces Initial Public Offering
RMB Shares began trading on the Shanghai Stock Exchange's STAR Market, making United Imaging Healthcare its largest IPO this year.

Shanghai, China – August 22nd, 2022 – United Imaging Healthcare (SSE: 688271), a leading global medical imaging and radiotherapy equipment company, began trading today on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange (SSE). As of press time, United Imaging Healthcare shares saw a rise of 72.91%, reaching CNY 189.99 per share, representing a market cap of over CNY 150 billion.

United Imaging Healthcare Bell Ringing Ceremony on the Shanghai Stock Exchange's STAR Market

United Imaging Healthcare expects to use the net proceeds from the STAR Offering to fund its research and development of next-generation products, including high-end medical imaging equipment. Part of the funding will also go to industrialization projects and marketing service network projects, and serve as supplementary operating capital.

"This listing on the STAR Market is significant to our long-term goals. We will now shoulder more responsibility, live up to greater expectations, and excel at corporate governance under the lens of public scrutiny. This will create sustainable long-term value and ensure we deliver compelling benefits to our customers, shareholders, employees, and society. Guided by our vision of leading healthcare innovation, we are becoming even more innovative and forward-thinking, with larger investments in R&D as well accelerated global expansion," said Xue Min, Chairman of United Imaging Group.

"Supported by our customers, partners and employees, United Imaging Healthcare has achieved huge leaps in the past 11 years. We will take this opportunity to focus squarely on innovation and core technology, and adhere to the philosophy of putting customers and patients first. We will ensure that we remain an innovation-oriented, technology-driven company that is well positioned to meet future trends and achieve the mission of 'Equal Healthcare for All' – making a difference in the healthcare industry in China and the world at large," said Al Zhang, Chairman & CEO of United Imaging Healthcare, at the listing ceremony.

By the end of 2021, United Imaging Healthcare had launched more than 80 groundbreaking products globally, including a Total-Body PET/CT, HD TOF PET/MR, 75cm Ultra-Wide Bore 3.0T MR, 640-Slice CT Scanner, and Fully Integrated CT-linac. Based on the company's top technologies, it has established collaborations with many world-renowned clinical and scientific research institutions, including UC Davis, Washington University in St. Louis, and Stony Brook University. So far, United Imaging Healthcare's products have been installed in medical and research institutions in more than 40 countries and regions, including the U.S., Italy, New Zealand and Japan.

A registration statement relating to these securities was declared effective by the China Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Founded in 2011, Shanghai United Imaging Healthcare Co., Ltd. is dedicated to providing global customers with high-performance medical imaging products, radiotherapy equipment, life science instruments and intelligent digital solutions. With our mission, 'To Bring Equal Healthcare for All,' and our vision, 'Leading Healthcare Innovation,' UIH is committed to creating more value for our customers and constantly improving the global accessibility of high-end medical equipment and services through in-depth cooperation with hospitals, universities, research institutions, and industry partners.